Granted Patent
B2
US 9,144,573 · App. 13/555,408 · Granted Sep 29, 2015
Prostaglandin transporter inhibitors
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention generally relates to prostaglandin transport. More specifically, the invention is directed to compounds that inhibit prostaglandin transport and subsequent COX-2 induction, and methods relating thereto.
Claims (11)
1. A compound having the structure:
wherein R1 is:
and wherein R2 is:
or a pharmaceutically acceptable salt, ester or tautomer thereof.
2. The compound of claim 1 having the structure:
or a pharmaceutically acceptable salt thereof.
3. The compound of claim 1 having the structure:
or a pharmaceutically acceptable salt thereof.
4. The compound of claim 2 which is:
5. The compound of claim 3 which is:
6. A composition comprising the compound of claim 1 in a pharmaceutically acceptable excipient.
Assignments (3)
MERGER AND CHANGE OF NAME
Recorded Feb 26, 2019
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.; ALBERT EINSTEIN COLLEGE OF MEDICINE
To: ALBERT EINSTEIN COLLEGE OF MEDICINE
Reel/Frame 048438/0275 →
CHANGE OF NAME
Recorded Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036888/0682 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 15, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036873/0672 →